Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | MAPKAPK2 | P49137 | 1/20 | 0.36 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.33 |
| ▸ | ADRA2B | P18089 | 2/20 | 0.33 |
| ▸ | ADRA2C | P18825 | 2/20 | 0.33 |
| ▸ | ADRA1D | P25100 | 2/20 | 0.33 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.33 |
| ▸ | ADRA1B | P35368 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | IDO1 | P14902 | 2/20 | 0.33 |
| ▸ | ROS1 | P08922 | 1/20 | 0.32 |
| ▸ | RPS6KB1 | P23443 | 1/20 | 0.32 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.32 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.32 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Alcohol SCHEMBL3675269 | 0.95 | OPRM1 (0.34) | KDM4EMAPKAPK2ADRA2AADRA2BADRA2C | |
| SCHEMBL5232178 | 0.76 | ROS1 (0.36) | KDM4EMAPKAPK2LMNACYP1A2CYP3A4 | |
| SCHEMBL3672089 | 0.74 | AOC3 (0.44) | KDM4EMAPKAPK2LMNACYP1A2CYP3A4 | |
| SCHEMBL3971384 | 0.70 | KDM4E (0.43) | KDM4EMAPKAPK2LMNACYP1A2CYP3A4 | |
| SCHEMBL19812908 | 0.66 | AOC3 (0.44) | CYP3A4AOC3 | |
| SCHEMBL19579734 | 0.66 | KDM4E (0.43) | KDM4EMAPKAPK2ADRA2AADRA2BADRA2C | |
| SCHEMBL10537508 | 0.66 | GAA (0.56) | KDM4EMAPKAPK2ADRA2AADRA2BADRA2C | |
| SCHEMBL30098521 | 0.65 | KDM4E (0.55) | KDM4EMAPKAPK2ADRA2AADRA2BADRA2C | |
| SCHEMBL1830567 | 0.65 | KDM4E (0.55) | KDM4EMAPKAPK2ADRA2AADRA2BADRA2C | |
| SCHEMBL28743874 | 0.65 | KDM4E (0.55) | KDM4EMAPKAPK2ADRA2AADRA2BADRA2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100041690-A1 | Co-Administration of Dopamine-Receptor Binding Compounds | DARPHARMA, INC. | 2010-02-18 | — | — | US | disclosed |
| US-20070254906-A1 | Method of Administration of Dopamine Receptor Agonists | DARPHARMA, INC. (US) | 2007-11-01 | — | — | US | disclosed |
| US-20070155720-A1 | Co-administration of dopamine-receptor binding compounds | DARPHARMA, INC. (US) | 2007-07-05 | — | — | US | disclosed |
| US-20070155720-A1 | Co-administration of dopamine-receptor binding compounds | DARPHARMA, INC. (US) | 2007-07-05 | — | — | US | disclosed |
| EP-1414457-B1 | CHIRAL DINAPSOLINE | PURDUE RESEARCH FOUNDATION (US) | 2007-06-20 | — | — | EP | disclosed |
| EP-1699450-A2 | CO-ADMINISTRATION OF DOPAMINE-RECEPTOR BINDING COMPOUNDS | Darpharma, INC. (US) | 2006-09-13 | — | — | EP | disclosed |
| US-7091212-B2 | Chiral dinapsoline | PURDUE RESEARCH FOUNDATION (US) | 2006-08-15 | — | — | US | disclosed |
| WO-2006012640-A2 | METHOD OF ADMINISTRATION OF DOPAMINE RECEPTOR AGONISTS | DARPHARMA, INC. (US) | 2006-02-02 | — | — | WO | disclosed |
| WO-2005062894-A2 | CO-ADMINISTRATION OF DOPAMINE-RECEPTOR BINDING COMPOUNDS | DARPHARMA, INC. (US) | 2005-07-14 | — | — | WO | disclosed |
| EP-1414457-A4 | CHIRAL DINAPSOLINE | PURDUE RESEARCH FOUNDATION (US) | 2004-12-29 | — | — | EP | disclosed |
| EP-1414457-A1 | CHIRAL DINAPSOLINE | PURDUE RESEARCH FOUNDATION (US) | 2004-05-06 | — | — | EP | disclosed |
| US-20040063741-A1 | Chiral dinapsoline | SIT SING-YUEN (US) | 2004-04-01 | — | — | US | disclosed |
| US-6645975-B1 | Reducing, deprotecting and optionally alkylating chemical intermediates to form 8,9-dihydroxy-2,3,7,11b-tetrahydro-1H-naphtho(1,2,3-de)isoquinoline, used as dopamine receptor agonists | PURDUE RESEARCH FOUNDATION | 2003-11-11 | — | — | US | disclosed |
| WO-2003013532-A1 | CHIRAL DINAPSOLINE | PURDUE RESEARCH FOUNDATION (US) | 2003-02-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100041690-A1 | Co-Administration of Dopamine-Receptor Binding Compounds | DRD2, DRD1, DRD3 | KDM4E 4742/4885MAPKAPK2 3254/4885ADRA2A 27/4885 |
| US-20070254906-A1 | Method of Administration of Dopamine Receptor Agonists | ADRA1D, DRD2, CHRM3 | KDM4E 4653/4885MAPKAPK2 2504/4885ADRA2A 8/4885 |
| US-20040063741-A1 | Chiral dinapsoline | NAP1L1, DDAH1, NAP1L4 | KDM4E 3583/4885MAPKAPK2 3541/4885ADRA2A 319/4885 |
| US-20070155720-A1 | Co-administration of dopamine-receptor binding compounds | DRD2, DRD1, DRD3 | KDM4E 4741/4885MAPKAPK2 3254/4885ADRA2A 26/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.